

          1. Severe liver disease (such as Child Pugh score >= C, AST> 5 times the upper limit);
             severe renal dysfunction (the glomerulus is 30ml / min / 1.73m2 or less)

          2. Positive pregnancy or breastfeeding or pregnancy test;

          3. In the 30 days before the screening assessment, have taken any experimental treatment
             drugs for COVID-19 (including off-label, informed consent use or trial-related);

          4. Those with a history of thromboembolism, except for those caused by PICC.
      